SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

SVB Leerink Maintains Outperform on FibroGen, Lowers Price Target to $80

SVB Leerink maintains FibroGen (NASDAQ:FGEN) with a Outperform and lowers the price target from $85 to $80.

Benzinga · 05/08/2020 16:59

SVB Leerink maintains FibroGen (NASDAQ:FGEN) with a Outperform and lowers the price target from $85 to $80.